MRI-guided laser ablation destroys cancer tumors successfully at Mayo Clinic
Physicians at Mayo Clinic’s Florida campus are among the first in the nation to use a technique known as MRI-guided laser ablation to heat up and destroy kidney and liver tumors. So far, five patients...
View ArticleHereditary, genetic cancer risks often left unexplored: new study
If you were dying from cancer, would you consider genetic testing? A recent study conducted by researchers from Virginia Commonwealth University Massey Cancer Center showed that most terminally ill...
View ArticleLiver cancer survival lengthened by sorafenib and doxorubicin
Patients with advanced liver cancer who were treated with sorafenib and doxorubicin lived twice as long those treated with doxorubicin alone, data from a phase II randomized study showed. Median...
View ArticleXgeva, helps prevent cancer-related bone injury, OKd by FDA
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone....
View ArticleLiver cancer may be treatable with radioactive element yttrium-90
Liver cancer has a new enemy. The latest weapon against inoperable liver cancer is so tiny that it takes millions of them per treatment, but according to interventional radiologists at the Indiana...
View ArticleFor liver cancer patients, radio ablation is effective, safe: study
Radiofrequency ablation is safe and effective in managing hepatocellular carcinoma in patients with cirrhosis, Italian researchers reported. In particular, it can be used repeatedly to treat the...
View ArticleCancer nausea drug causes arrhythmias: FDA warning
The FDA is warning against use of the injectable form of dolasetron mesylate (Anzemet) to prevent nausea and vomiting in patients undergoing cancer chemotherapy, as new data indicate the drug can...
View Article20 percent of survivors, two years post diagnosis, have chronic cancer pain
The study, published online ahead of print in the American Cancer Society’s journal Cancer, gives new insight on issues in cancer survivorship among the growing number of U.S. cancer survivors. More...
View ArticleNew real-time breast, liver, lung, and pancreatic tumor tracking technique...
Medical physicists at Thomas Jefferson University and Jefferson’s Kimmel Cancer Center have demonstrated a new real-time tumor tracking technique that can help minimize the amount of radiation...
View ArticleTumors do not necessarily grow gradually, says new research
A new method of analyzing cancerous tumors developed by scientists at Cold Spring Harbor Laboratory (CSHL) suggests that tumors may not evolve gradually, but rather in punctuated or staccato-like...
View ArticleCancer breakthrough may be possible with nanomedicine discovery
Soon, drug delivery that precisely targets cancerous cells without exposing the healthy surrounding tissue to the medication’s toxic effects will no longer be an oncologist’s dream but a medical...
View ArticleWhat all cancers have in common, updated
Renowned cancer researchers Robert Weinberg, a Founding Member of Whitehead Institute, and Douglas Hanahan, Director of the Swiss Institute for Experimental Cancer Research (ISREC) have updated their...
View ArticleCancer survivors number 12,000,000 in US
The number of cancer survivors in the United States increased to 11.7 million in 2007, according to a report released by the Centers for Disease Control and Prevention and the National Cancer...
View ArticleHHS issues Combating the Silent Epidemic of Viral Hepatitis: Action Plan for...
Hepatitis is a hidden epidemic with significant public health consequences. * An estimated 3.5-5.3 million persons are living with viral hepatitis in the United States, and millions more are at risk...
View ArticleLiver cancer cells killed by Celebrex: OSU study
The anti-inflammatory drug celecoxib, known by the brand name Celebrex, triggers liver cancer cell death by reacting with a protein in a way that makes those cells commit suicide, according to a new...
View ArticleAdvanced melanoma vaccine improves response rate, survival: first cancer...
A vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2,...
View ArticleGenetic variant linked to development of liver cancer in hepatitis C virus...
A genome-wide study by researchers at the RIKEN Center for Genomic Medicine, Hiroshima University Hospital and Sapporo-Kosei General Hospital has identified a genetic variant associated with the...
View ArticleWhy men’s stomach, liver, colon cancer risk is higher: new study from MIT
Several types of cancer, including stomach, liver and colon, are far more common in men than in women. Some scientists have theorized that differences in lifestyle, such as diet and smoking, may...
View ArticleSaffron shows promise in preventing liver cancer
Spice promotes apoptosis and inhibits growth of cancerous cells in animal models New research suggests that saffron provides a significant chemopreventive effect against liver cancer in animal models....
View ArticleLiver cancer increasing in low risk countries, decreasing in high risk countries
ATLANTA — October 6, 2011 — A new study finds liver cancer incidence rates continue to increase in some low-risk parts of the world such as North America, and are decreasing in some of the highest...
View Article